Related Experiment Videos
Ovarian cancer: latest gains establish new battle fronts
Journal of the National Cancer Institute
|June 21, 1995
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Pembrolizumab versus ipilimumab for advanced melanoma: 10-year follow-up of the phase III KEYNOTE-006 study.
Annals of oncology : official journal of the European Society for Medical Oncology·2024
Outcomes of patients with non-melanoma solid tumours receiving self-funded pembrolizumab at Chris O'Brien Lifehouse.
Internal medicine journal·2016
Progression of KRAS mutant pancreatic adenocarcinoma during vemurafenib treatment in a patient with metastatic melanoma.
Internal medicine journal·2014
Endocrine Biomarker Changes in a Randomised Low-Dose Tamoxifen Trial for Breast Cancer Prevention.
Journal of the National Cancer Institute·2026
Treatment Effect Discrepancy Between PFS and OS in Antibody-Drug Conjugate Trials for Metastatic Breast Cancer: A Meta-Epidemiologic Analysis.
Journal of the National Cancer Institute·2026
Integrating genetic predictors into subsequent breast cancer risk prediction in survivors of childhood cancer.
Journal of the National Cancer Institute·2026
(Neo)adjuvant approvals for solid tumors by the US Food and Drug Administration 2010-2023.
Journal of the National Cancer Institute·2026
The floor, not the ceiling: industry ties across the cancer ecosystem.
Journal of the National Cancer Institute·2026
Cancer incidence trends among Asian American, Native Hawaiian, and Pacific Islander populations in the United States, 2000-2022.
Journal of the National Cancer Institute·2026
Myocardial infarction and lung cancer research from 1995 to 2026: a WoSCC- and PubMed-based bibliometric analysis.
Journal of thoracic disease·2026
Procyanidin C1 combined with olaparib induces senescence in BRCA1-proficient breast cancer cells.
American journal of cancer research·2026
Erratum: DOT1L promotes cell proliferation and invasion by epigenetically regulating STAT5B in renal cell carcinoma.
American journal of cancer research·2026
CircFN1 promotes invasion of papillary thyroid carcinoma cells by activating the PI3K/AKT pathway via the miR-29a/TRIB2 axis.
Translational cancer research·2026
The potential role of NLRP3 inflammasome in integrating redox, metabolic, and inflammatory signals during follicular development: a hypothesis-driven redox-metabolic integrator framework.
Frontiers in cell and developmental biology·2026